187 related articles for article (PubMed ID: 9159310)
1. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Bresson C; Fournier V; Bouhaddi M; Chalopin JM; Saint-Hillier Y; Regnard J
Am J Kidney Dis; 1997 May; 29(5):746-53. PubMed ID: 9159310
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Henriet MT; Bresson C; Regnard J; Saint-Hillier Y
Transplantation; 1995 Jun; 59(12):1690-4. PubMed ID: 7604439
[TBL] [Abstract][Full Text] [Related]
3. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
[TBL] [Abstract][Full Text] [Related]
5. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
Maruani G; Hertig A; Paillard M; Houillier P
J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
[TBL] [Abstract][Full Text] [Related]
6. Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Henriet MT; Bresson C; Regnard J; Saint-Hillier Y
Am J Nephrol; 1995; 15(3):238-44. PubMed ID: 7618649
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover.
Cohen A; Addonizio LJ; Lamour JM; Addesso V; Staron RB; Gao P; Shane E
J Heart Lung Transplant; 2005 Jun; 24(6):696-702. PubMed ID: 15949729
[TBL] [Abstract][Full Text] [Related]
9. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
[TBL] [Abstract][Full Text] [Related]
10. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
[TBL] [Abstract][Full Text] [Related]
12. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.
Cruz DN; Wysolmerski JJ; Brickel HM; Gundberg CG; Simpson CA; Mitnick MA; Kliger AS; Lorber MI; Basadonna GP; Friedman AL; Insogna KL; Bia MJ
Transplantation; 2001 Jul; 72(1):83-8. PubMed ID: 11468539
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid function in normocalcemic renal transplant recipients: evaluation by calcium infusion.
Mitlak BH; Alpert M; Lo C; Delmonico F; Neer RM
J Clin Endocrinol Metab; 1991 Feb; 72(2):350-5. PubMed ID: 1991804
[TBL] [Abstract][Full Text] [Related]
14. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.
Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP
Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527
[TBL] [Abstract][Full Text] [Related]
15. Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.
Goodman WG; Misra S; Veldhuis JD; Portale AA; Wang HJ; Ament ME; Salusky IB
Am J Clin Nutr; 2000 Feb; 71(2):560-8. PubMed ID: 10648272
[TBL] [Abstract][Full Text] [Related]
16. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
[TBL] [Abstract][Full Text] [Related]
17. Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol.
Lobo PI; Cortez MS; Stevenson W; Pruett TL
Clin Transplant; 1995 Aug; 9(4):277-81. PubMed ID: 7579733
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone: a determinant of posttransplant blood pressure regulation.
McCarron DA; Muther RS; Plant SB; Krutzik S
Am J Kidney Dis; 1981 Jul; 1(1):38-44. PubMed ID: 7036714
[TBL] [Abstract][Full Text] [Related]
19. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism.
Schwarz A; Merkel S; Leitolf H; Haller H
Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318
[TBL] [Abstract][Full Text] [Related]
20. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
